Text resize: A A A

milestones

Direct marketing of Ibuprofen Rx is the first step in building our commercial organization in the United States market and exemplifies the fact that we can manage our vertically integrated supply chain,

Mark Hartman, was President, North America Generics,
Dr. Reddy's. Worked with
Dr. Reddy's from April 2002- Nov 2008

Launches Ibuprofen, first generic product to be marketed under the “Dr. Reddy’s” label in the US

Dr. Reddy’s launches Ibuprofen in the U.S. in January 2003. It is the first generic product to be marketed under the “Dr. Reddy’s” label in the US. The Ibuprofen launch is a significant event in Dr. Reddy's' endeavor to build a strong and sustainable US generics business.

Dr. Reddy’s releases its first “Corporate Safety, Health & Environment (SHE) Report for the year 2002 - 2003” on September 15, 2003 becoming the first Indian Pharma company to release a SHE report.

Click to read related memories

2003
Ibuprofen- the first generic product to be marketed under the “Dr. Reddy’s” label in the US